Mitiglinide
Sponsors
Kissei Pharmaceutical Co., Ltd., Elixir Pharmaceuticals, JW Pharmaceutical, Seoul National University Hospital, Samsung Medical Center
Conditions
DiabetesDiabetes Mellitus, Type 2Healthy ParticipantsLiver DysfunctionMasked HypertensionObesityOverweightType 2 Diabetes
Phase 1
Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin
CompletedNCT01422590
Start: 2010-05-31End: 2011-04-30Updated: 2011-09-07
A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy Participants
RecruitingNCT07444424
Start: 2026-03-13End: 2026-07-02Target: 32Updated: 2026-03-30
Phase 3
Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic Patients
CompletedNCT00461617
Start: 2006-08-31End: 2007-07-31Updated: 2008-10-21
Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus
CompletedNCT00519142
Start: 2007-08-31End: 2008-10-31Updated: 2009-09-17
Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
CompletedNCT01037842
Start: 2006-08-31End: 2008-05-31Updated: 2009-12-23
Phase 4
Glufast On Insulin Glargine Trial in Type 2 DM
CompletedNCT00663884
Start: 2008-02-29End: 2009-09-30Updated: 2012-03-30
Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
CompletedNCT02143765
Start: 2014-05-31End: 2015-12-31Updated: 2016-07-14
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
NCT02503943
Start: 2015-05-31End: 2016-09-30Target: 90Updated: 2015-07-21
Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)
CompletedNCT04349696
Start: 2014-02-11End: 2018-04-30Updated: 2021-04-30